OpenURL Connection Search

Select item for more details and to access through your institution.

A multicenter randomized controlled trial of recombinant human thrombopoietin treatment in patients with primary immune thrombocytopenia.
Published in:
International Journal of Hematology, 2012, v. 96, n. 2, p. 222, doi. 10.1007/s12185-012-1124-8
By:
- Wang, Shujie;
- Yang, Renchi;
- Zou, Ping;
- Hou, Ming;
- Wu, Depei;
- Shen, Zhixiang;
- Lu, Xijing;
- Li, Yan;
- Chen, Xiequn;
- Niu, Ting;
- Sun, Hui;
- Yu, Li;
- Wang, Zhao;
- Zhang, Yin;
- Chang, Naibai;
- Zhang, Gaokui;
- Zhao, Yongqiang
Publication type:
Article
Sodium salicylate-triggered apoptosis in HL-60 cells depends on caspase-8 activation.
Published in:
2002
By:
- Chen, Xiequn;
- Wan, Youfeng;
- Bai, Qingxian;
- Zhang, Weiping;
- Zhu, Huafeng
Publication type:
journal article
Mammalian Diaphanous-Related Formin 1 Regulates GSK3β-Dependent Microtubule Dynamics Required for T Cell Migratory Polarization.
Published in:
PLoS ONE, 2013, v. 8, n. 11, p. 1, doi. 10.1371/journal.pone.0080500
By:
- Dong, Baoxia;
- Zhang, Steven S.;
- Gao, Wen;
- Su, Haichun;
- Chen, Jun;
- Jin, Fuzi;
- Bhargava, Ajay;
- Chen, Xiequn;
- Jorgensen, Lars;
- Alberts, Arthur S.;
- Zhang, Jinyi;
- Siminovitch, Katherine A.
Publication type:
Article
Systematic analysis of prognostic significance, functional enrichment and immune implication of STK10 in acute myeloid leukemia.
Published in:
BMC Medical Genomics, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s12920-022-01251-7
By:
- Bi, Lei;
- Jia, Shuangshuang;
- Hu, Wuyue;
- Su, Xiaoli;
- Chen, Xiequn;
- Tang, Hailong
Publication type:
Article
Synergistic Efficacy of the Demethylation Agent Decitabine in Combination With the Protease Inhibitor Bortezomib for Treating Multiple Myeloma Through the Wnt/β-Catenin Pathway.
Published in:
Oncology Research, 2019, v. 27, n. 6, p. 729, doi. 10.3727/096504018X15443011011637
By:
- Yulong Jin;
- Li Xu;
- Xiaodong Wu;
- Juan Feng;
- Mimi Shu;
- Hongtao Gu;
- Guangxun Gao;
- Jinyi Zhang;
- Baoxia Dong;
- Xiequn Chen
Publication type:
Article
The evolution of preexisting primary immune thrombocytopenia after COVID-19 onset: A nationally representative, prospective, multicentre, observational study.
Published in:
Annals of Hematology, 2024, v. 103, n. 5, p. 1549, doi. 10.1007/s00277-024-05720-0
By:
- Fu, Haixia;
- Cai, Xuan;
- Cui, Lijuan;
- Nong, Weixia;
- Li, Wenqian;
- Mei, Heng;
- Yang, Tonghua;
- Yue, Han;
- Huang, Qiusha;
- An, Zhuoyu;
- Wu, Yejun;
- Huang, Xiaojun;
- Zhang, Xiaohui;
- Meng, Tongfei;
- Gao, Sujun;
- Li, Jianyong;
- Chen, Xiequn;
- Shu, Mimi;
- Wang, Shaoyuan;
- Huang, Xiaobing
Publication type:
Article
Aponermin or placebo in combination with thalidomide and dexamethasone in the treatment of relapsed or refractory multiple myeloma (CPT-MM301): a randomised, double-blinded, placebo-controlled, phase 3 trial.
Published in:
BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11489-8
By:
- Xia, Zhongjun;
- Leng, Yun;
- Fang, Baijun;
- Liang, Yang;
- Li, Wei;
- Fu, Chengcheng;
- Yang, Linhua;
- Ke, Xiaoyan;
- Jiang, Hua;
- Weng, Jianyu;
- Liu, Li;
- Zhao, Yaozhong;
- Zhang, Xuejun;
- Huang, Zhongxia;
- Liu, Aichun;
- Shi, Qingzhi;
- Gao, Yuhuan;
- Chen, Xiequn;
- Pan, Ling;
- Cai, Zhen
Publication type:
Article
Ibrutinib versus rituximab in relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma: a randomized, open‐label phase 3 study.
Published in:
Cancer Medicine, 2018, v. 7, n. 4, p. 1043, doi. 10.1002/cam4.1337
By:
- Huang, Xiaojun;
- Qiu, Lugui;
- Jin, Jie;
- Zhou, Daobin;
- Chen, Xiequn;
- Hou, Ming;
- Hu, Jianda;
- Hu, Yu;
- Ke, Xiaoyan;
- Li, Junmin;
- Liang, Yingmin;
- Liu, Ting;
- Lv, Yue;
- Ren, Hanyun;
- Sun, Aining;
- Wang, Jianmin;
- Zhao, Chunting;
- Salman, Mariya;
- Sun, Steven;
- Howes, Angela
Publication type:
Article
Pharmacological inhibition of EZH2 combined with DNA-damaging agents interferes with the DNA damage response in MM cells.
Published in:
Molecular Medicine Reports, 2019, v. 19, n. 5, p. 4249
By:
- Xu, Li;
- Tang, Hailong;
- Wang, Kai;
- Zheng, Yanhua;
- Feng, Juan;
- Dong, Hongjuan;
- Jin, Yulong;
- Cao, Chun;
- Chen, Xiequn;
- Gao, Guangxun
Publication type:
Article
Increased Expression of TIGIT on CD4<sup>+</sup> T Cells Ameliorates Immune-Mediated Bone Marrow Failure of Aplastic Anemia.
Published in:
Journal of Cellular Biochemistry, 2014, v. 115, n. 11, p. 1918, doi. 10.1002/jcb.24862
By:
- Zhang, Tao;
- Wang, Jianhong;
- Zhou, Xingchun;
- Liang, Rong;
- Bai, Qingxian;
- Yang, Lan;
- Gu, Hongtao;
- Gao, Guangxun;
- Dong, Baoxia;
- Zhu, Huafeng;
- Chen, Xiequn
Publication type:
Article
Modified Bortezomib, Adriamycin and Dexamethasone (PAD) Regimen in Advanced Multiple Myeloma.
Published in:
Pathology & Oncology Research, 2014, v. 20, n. 4, p. 987, doi. 10.1007/s12253-014-9785-7
By:
- Zhang, Yongqing;
- Liu, Hongjuan;
- Chen, Xiequn;
- Bai, Qingxian;
- Liang, Rong;
- Shi, Bing;
- Liu, Lihui;
- Tian, DengMei;
- Liu, Mingjuan
Publication type:
Article
CD147 and VEGF Co-expression Predicts Prognosis in Patients with Acute Myeloid Leukemia.
Published in:
Japanese Journal of Clinical Oncology, 2010, v. 40, n. 11, p. 1046, doi. 10.1093/jjco/hyq098
By:
- Fu, Jufang;
- Fu, Jianfang;
- Chen, Xiequn;
- Zhang, Yongqing;
- Gu, Hongtao;
- Bai, Yanni
Publication type:
Article
P-211: Phase 2 MARCH study: ATG-010 plus Dexamethasone in Chinese relapsed/refractory Multiple Myeloma (RRMM) patients previously treated with an immunomodulatory agent (IMiD) and a proteasome inhibitor (PI).
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S155, doi. 10.1016/S2152-2650(21)02338-7
By:
- Lugui Qiu;
- Weijun Fu;
- Chengcheng Fu;
- Wenming Chen;
- Chunkang Chang;
- Baijun Fang;
- Gang An;
- Yongqiang Wei;
- Zhen Cai;
- Sujun Gao;
- Jianyu Weng;
- Lijun Chen;
- Hongmei Jing;
- Fei Li;
- Zhuogang Liu;
- Xiequn Chen;
- Jing Liu;
- Ling Li;
- Yang Yu;
- Aihua Wang
Publication type:
Article
P-192: Circularly permuted TRAIL (CPT) combined with Thalidomide and Dexamethasone in patients with relapsed/refractory Multiple Myeloma: a randomized, double-blind, placebo-controlled phase 3 study.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S143, doi. 10.1016/S2152-2650(21)02319-3
By:
- Wenming Chen;
- Zhongjun Xia;
- Baijun Fang;
- Chengcheng Fu;
- Wei Li;
- Linhua Yang;
- Xiaoyan Ke;
- Hua Jiang;
- Jianyu Weng;
- Li Liu;
- Yaozhong Zhao;
- Xuejun Zhang;
- Aichun Liu;
- Zhongxia Huang;
- Qingzhi Shi;
- Yuhuan Gao;
- Xiequn Chen;
- Ling Pan;
- Zhen Cai;
- Zhao Wang
Publication type:
Article
Improved PFS and OS With Ixazomib Plus Lenalidomide-Dexamethasone (IRd) vs Placebo-Rd in Patients (pts) With Relapsed/Refractory Multiple Myeloma (RRMM): Final Data From the Phase 3 China Continuation of TOURMALINE-MM1.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e67, doi. 10.1016/j.clml.2017.03.121
By:
- Hou, Jian;
- Jin, Jie;
- Xu, Yan;
- Wu, Depei;
- Ke, Xiaoyan;
- Daobin, Zhou;
- Lu, Jin;
- Du, Xin;
- Chen, Xiequn;
- Li, Junmin;
- Liu, Jing;
- Gupta, Neeraj;
- Hanley, Michael;
- Li, Hongmei;
- Hua, Zhaowei;
- Wang, Bingxia;
- Zhang, Xiaoquan;
- Wang, Hui;
- van de Velde, Helgi;
- Richardson, Paul
Publication type:
Article
BMI-1 is important in bufalin.induced apoptosis of K562 cells.
Published in:
Molecular Medicine Reports, 2014, v. 9, n. 4, p. 1209, doi. 10.3892/mmr.2014.1980
By:
- XIAOYUN LIAN;
- HAO WANG;
- XUCANG WEI;
- YI WANG;
- QISHAN WANG;
- LIANG GUO;
- YUAN ZHAO;
- XIEQUN CHEN
Publication type:
Article
Monoclonal Antibodies versus Histone Deacetylase Inhibitors in Combination with Bortezomib or Lenalidomide plus Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma: An Indirect-Comparison Meta-Analysis of Randomized Controlled Trials.
Published in:
2018
By:
- Zheng, Yanhua;
- Shen, Hongyuan;
- Xu, Li;
- Feng, Juan;
- Tang, Hailong;
- Zhang, Na;
- Chen, Xiequn;
- Gao, Guangxun
Publication type:
journal article
Chidamide epigenetically represses autophagy and exerts cooperative antimyeloma activity with bortezomib.
Published in:
Cell Death & Disease, 2020, v. 11, n. 4, p. 1, doi. 10.1038/s41419-020-2414-3
By:
- Xu, Li;
- Feng, Juan;
- Tang, Hailong;
- Dong, Ying;
- Shu, Mimi;
- Chen, Xiequn
Publication type:
Article
Randomized, double-blind, placebo-controlled phase III study of ixazomib plus lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma: China Continuation study.
Published in:
Journal of Hematology & Oncology, 2017, v. 10, p. 1, doi. 10.1186/s13045-017-0501-4
By:
- Jian Hou;
- Jie Jin;
- Yan Xu;
- Depei Wu;
- Xiaoyan Ke;
- Daobin Zhou;
- Jin Lu;
- Xin Du;
- Xiequn Chen;
- Junmin Li;
- Jing Liu;
- Gupta, Neeraj;
- Hanley, Michael J.;
- Hongmei Li;
- Zhaowei Hua;
- Bingxia Wang;
- Xiaoquan Zhang;
- Hui Wang;
- van de Velde, Helgi;
- Richardson, Paul G.
Publication type:
Article
Selinexor plus low-dose dexamethasone in Chinese patients with relapsed/refractory multiple myeloma previously treated with an immunomodulatory agent and a proteasome inhibitor (MARCH): a phase II, single-arm study.
Published in:
2022
By:
- Qiu, Lugui;
- Xia, Zhongjun;
- Fu, Chengcheng;
- Chen, Wenming;
- Chang, Chunkang;
- Fang, Baijun;
- An, Gang;
- Wei, Yongqiang;
- Cai, Zhen;
- Gao, Sujun;
- Weng, Jianyu;
- Chen, Lijuan;
- Jing, Hongmei;
- Li, Fei;
- Liu, Zhuogang;
- Chen, Xiequn;
- Liu, Jing;
- Wang, Aihua;
- Yu, Yang;
- Xiang, Wenxi
Publication type:
journal article
New progress in the study of germline susceptibility genes of myeloid neoplasms.
Published in:
Oncology Letters, 2021, v. 21, n. 4, p. N.PAG, doi. 10.3892/ol.2021.12578
By:
- Bi, Lei;
- Ma, Tianyuan;
- Li, Xu;
- Wei, Lai;
- Liu, Zinuo;
- Feng, Bingyue;
- Dong, Baoxia;
- Chen, Xiequn
Publication type:
Article
CD5-mediated inhibition of TCR signaling proceeds normally in the absence of SHP-1.
Published in:
International Journal of Molecular Medicine, 2016, v. 38, n. 1, p. 45, doi. 10.3892/ijmm.2016.2592
By:
- BAOXIA DONG;
- SOMANI, ALLY-KHAN;
- LOVE, PAUL E.;
- XUAN ZHENG;
- XIEQUN CHEN;
- JINYI ZHANG
Publication type:
Article

Found: 22